本页面由Tiger Trade Technology Pte. Ltd.提供服务

众巢医学

1.39
-0.2000-12.58%
盘后:1.390.00000.00%19:43 EDT
成交量:11.73万
成交额:17.29万
市值:616.71万
市盈率:0.00
高:1.59
开:1.59
低:1.35
收:1.59
52周最高:46.56
52周最低:0.1428
股本:443.68万
流通股本:322.94万
量比:1.02
换手率:3.63%
股息:- -
股息率:- -
每股收益(TTM):-343.3536
每股收益(LYR):-114.7000
净资产收益率:-24.88%
总资产收益率:-15.47%
市净率:0.33
市盈率(LYR):-0.01

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/05

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/26

SEC问询函

Form CORRESP - Correspondence
2026/05/26

SEC问询函

Form CORRESP - Correspondence
2026/05/22

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/05/07

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2026/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/15

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/08/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/07/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/21

SEC问询函

Form CORRESP - Correspondence
2025/06/07

SEC问询函

Form CORRESP - Correspondence
2025/05/20

SEC问询函

Form CORRESP - Correspondence
2025/05/07

SEC问询函

Form CORRESP - Correspondence
2025/04/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/27

SEC问询函

Form CORRESP - Correspondence
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/12

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership